> ## Content Index
> Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# DynPort Vaccine Company
- URL: https://www.whiteroseintelligence.com/dynport-vaccine-company/
- Published: 1999-01-02T15:27:00.000Z
- Updated: 2025-01-02T15:06:04.000Z
- Author: Liam Sturgess
- Tags: Profiles, #docs, #organization

**DynPort Vaccine Company LLC (DVC)** is an American biotechnology company based in Frederick, Maryland. It is “dedicated to the development and licensure of safe and efficacious biodefense vaccines.”

## History

DynPort was founded in 1997 as a joint venture between defense contractor DynCorp and Porton International, a wholly-owned subsidiary of Ipsen.[\[1\]](#fn1)[\[2\]](#fn2) That year, the [United States Department of Defense](https://www.whiteroseintelligence.com/United-States-Department-of-Defense) (DoD), through its Joint Vaccine Acquisition Program (JVAP), contracted DynPort to manufacture 300,000 doses of a new smallpox vaccine for the military.[\[3\]](#fn3) The company began working on the project in 1998.

Dr. [Robert Malone](https://www.whiteroseintelligence.com/Robert-Malone) joined the company as Associate Director of Clinical Research in 2002, leaving the position in 2003.[\[4\]](#fn4)

On March 30, 2004, Commonwealth Biotechnologies announced it had entered a partnership with DynPort through which the companies would “co-venture wherever appropriate to compete for new biodefense vaccine development funding.”[\[2:1\]](#fn2)

## Organization

| Name                                                                 | Position                                                               | Notes                                                                             |
| -------------------------------------------------------------------- | ---------------------------------------------------------------------- | --------------------------------------------------------------------------------- |
| Terry Irgens                                                         | President (former)                                                     | Logicon, Defense Personnel Support Center, Naval Medical Logistics Command (NMLC) |
| Michael Langford                                                     | Senior Vice President & Chief Scientific Officer (former)[\[5\]](#fn5) | United States Army, United States Army Acquisition Corps                          |
| [Robert Malone](https://www.whiteroseintelligence.com/Robert-Malone) | Associate Director of Clinical Research (former)                       | Worked on DynPort's smallpox vaccine                                              |

## Products

DynPort developed vaccines and related biologicals for a number of diseases including:[\[6\]](#fn6)

- Anthrax vaccine
- Botulinum multivalent vaccine
- Plague vaccine
- Smallpox vaccine
- Tularemia vaccine
- Vaccinia immune globulin
- Venezuelan equine encephalitis (VEE) vaccine

## External links

- [Campfire Wiki](https://www.campfire.wiki/doku.php?id=pharmaceutical%5Fcompanies:dynport%5Fvaccine%5Fcompany)
- [Housatonic](https://sites.google.com/housatonicits.com/home0004/research/dynport-vaccine-company)
- [LinkedIn](https://www.linkedin.com/company/dynport-vaccine-company-llc-a-csra-company/)
- [PitchBook](https://pitchbook.com/profiles/company/166273-57)
- [SourceWatch](https://sourcewatch.org/index.php/DynPort)
- [Website (earliest archive)](https://web.archive.org/web/20021123050047/http://www.dynport.com/)

### Further reading

- April 9, 2020: "[A Killer Enterprise: How One of Big Pharma’s Most Corrupt Companies Plans to Corner the Covid-19 Cure Market](https://www.thelastamericanvagabond.com/killer-enterprise-how-big-pharmas-most-corrupt-companies-plans-corner-covid-19-cure-market/)" by [Whitney Webb](https://www.whiteroseintelligence.com/Whitney-Webb), published by *The Last American Vagabond*

---

1. Hogan, B. (January/February 2002). *A Biodefense Boondoggle.* Mother Jones. <https://web.archive.org/web/20051129154849/http://www.motherjones.com//news/outfront/2002/01/biodefense.html> [↩︎](#fnref1)
2. Harris, R. B. (2004, March 30). *Commonwealth Biotechnologies, Inc. Launches New Biodefense Business Initiative.* Securities and Exchange Commission. <http://archive.today/2023.03.20-195208/https://www.sec.gov/Archives/edgar/data/1042418/000119312504053263/dex991.htm> [↩︎](#fnref2) [↩︎](#fnref2:1)
3. Cohen, J., & Marshall, E. (2001, October 19). *Vaccines for Defense: A System in Distress.* UCLA Department of Epidemiology. <http://archive.today/2021.12.13-221406/http://www.ph.ucla.edu/epi/bioter/vaccinesfordefense.html> [↩︎](#fnref3)
4. Malone, R. W. (2017, March). *RWM CV.* Squarespace. <https://web.archive.org/web/20230119104151/https://static1.squarespace.com/static/550b0ac4e4b0c16cdea1b084/t/58e5406b5016e1f1acacae75/1491419246742/RWM+CV+March+2017.pdf> [↩︎](#fnref4)
5. *Leadership.* DynPort. Retrieved December 8, 2002, from <https://web.archive.org/web/20021208085639/http://www.dynport.com/leadership.htm> [↩︎](#fnref5)
6. *Products.* DynPort. Retrieved December 8, 2002, from <https://web.archive.org/web/20021208091702/http://www.dynport.com/products.htm> [↩︎](#fnref6)